Cover Image
Issue Information
Pan‐genotypic treatment regimens for hepatitis C virus
Simeprevir plus sofosbuvir for eight or 12 weeks in treatment‐naïve and treatment‐experienced hepatitis C virus genotype 4 patients with or without cirrhosis
Social capital strategies to enhance hepatitis C treatment awareness and uptake among men in prison
Higher incidence of HCV in females compared to males who inject drugs
Decline of cellular activation in non‐B cells after rituximab treatment in hepatitis C‐associated mixed cryoglobulinemia vasculitis
Classification and regression tree analysis of acute‐on‐chronic hepatitis B liver failure
Tenofovir versus tenofovir plus entecavir for chronic hepatitis B with lamivudine resistance and entecavir resistance
Baseline hepatitis B core antibody predicts treatment response in chronic hepatitis B patients receiving long‐term entecavir
Induction of humoral and cellular immune response to hepatitis B virus (HBV) vaccine can be upregulated by CpG oligonucleotides complexed with Dectin‐1 ligand
A novel hepatitis B virus subgenotype D10 circulating in Ethiopia
Rapid improvement in liver fibrosis in HCV‐infected patients with or without HIV infection and DAA‐induced SVR